Overcoming Linsitinib intrinsic resistance through inhibition of nuclear factor‐κB signaling in esophageal squamous cell carcinoma

The aim of this study is to evaluate the efficacy of insulin‐like growth factor 1 receptor (IGF‐1R) inhibitor Linsitinib, in esophageal squamous cell carcinoma (ESCC), and to characterize special biomarker to screen Linsitinib‐sensitive patients as well as explore the molecular‐resistant mechanism t...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Med
Asıl Yazarlar: Wu, Junzhou, Chen, Kaiyan, Zhang, Fanrong, Jin, Jiaoyue, Zhang, Nan, Li, Dan, Ying, Lisha, Chen, Wei, Yu, Herbert, Mao, Weimin, Su, Dan
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2017
Konular:
Cancer Biology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5463077/
https://ncbi.nlm.nih.gov/pubmed/28440057
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1068
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller